Clinical Trial Update: Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating tasimelteon for autism spectrum disorder with sleep disturbances is underway or ongoing, with unclear status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Neurological Disorder
• Sleep Disorder
• Sleep Disturbance

Drugs mentioned

• Tasimelteon (tasimelteon)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Autism Spectrum Disorder, Sleep Disorder | Phase 3 | Status: UNKNOWN